Supraciliary stenting with the CyPass Micro-Stent effectively lowers IOP as a surgical treatment for glaucoma , precluding the need for more invasive glaucoma surgery in > 80 % of patients at 1 year , therebyreducing postoperative glaucoma surgical complications .